Search filters

List of works by Tom Thuren

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure

scientific article published on 01 March 2019

Anti-Inflammatory Therapy with Canakinumab for the Prevention and Management of Diabetes

scientific article published on 3 March 2018

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

scientific article published on 27 August 2017

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

scientific article published on 25 August 2017

Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk: A Secondary Analysis of CANTOS

scientific article published on 30 December 2019

Effects of Interleukin-1β Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial

scientific article published on 24 March 2020

Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement: Exploratory Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

scientific article published on 04 August 2020

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

scientific article published on 5 November 2012

Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial

scientific article published on 01 October 2020

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease

scientific article published on 01 May 2018

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) ⬇️

scientific article published on September 14, 2011

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)

scientific article published on 01 October 2018

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

scientific article published on 13 November 2017

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial

scientific article published on 18 September 2018

Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis

scientific article published on 01 September 2019

Paulina is supported by:

About Paulina

Help